High Prevalence of ST131 Isolates Producing CTX-M-15 and CTX-M-14 among Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates from Canada

Antimicrobial Agents and Chemotherapy
2010.0

Abstract

Phenotypic and genotypic methods were used to characterize extended-spectrum-beta-lactamase (ESBL)-producing Escherichia coli isolated in 2007 from 11 different Canadian medical centers. Of the 209 ESBL-producing E. coli isolates tested, 148 (71%) produced CTX-M-15, 17 (8%) produced CTX-M-14, 5 (2%) produced CTX-M-3, and 1 produced CTX-M-27. Overall, 96 (46%) of the ESBL producers belonged to clonal complex ST131, with the highest prevalence in Brampton, Calgary, and Winnipeg. ST131 is an important cause of community onset urinary tract infections due to ESBL-producing E. coli across Canada.

Knowledge Graph

Similar Paper

High Prevalence of ST131 Isolates Producing CTX-M-15 and CTX-M-14 among Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates from Canada
Antimicrobial Agents and Chemotherapy 2010.0
Molecular Characteristics of Travel-Related Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates from the Calgary Health Region
Antimicrobial Agents and Chemotherapy 2009.0
Molecular Epidemiology of CTX-M-Producing Escherichia coli Isolates at a Tertiary Medical Center in Western Pennsylvania
Antimicrobial Agents and Chemotherapy 2009.0
Extended-Spectrum β-Lactamases of the CTX-M Type Now in Switzerland
Antimicrobial Agents and Chemotherapy 2007.0
bla <sub>CTX-M</sub> Genes in Escherichia coli Strains from Croatian Hospitals Are Located in New ( bla <sub>CTX-M-3a</sub> ) and Widely Spread ( bla <sub>CTX-M-3a</sub> and bla <sub>CTX-M-15</sub> ) Genetic Structures
Antimicrobial Agents and Chemotherapy 2009.0
Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Strains in Various Types of Private Health Care Centers
Antimicrobial Agents and Chemotherapy 2007.0
Spread of Extended-Spectrum β-Lactamase CTX-M-Producing Escherichia coli Clinical Isolates in Community and Nosocomial Environments in Portugal
Antimicrobial Agents and Chemotherapy 2007.0
First Report of the Emergence of CTX-M-Type Extended-Spectrum β-Lactamases (ESBLs) as the Predominant ESBL Isolated in a U.S. Health Care System
Antimicrobial Agents and Chemotherapy 2007.0
High Prevalence of CTX-M-Type β-Lactamases among Clinical Isolates of Enterobacteriaceae in Bamako, Mali
Antimicrobial Agents and Chemotherapy 2009.0
Comparison of Antimicrobial Resistance Profiles among Extended-Spectrum-β-Lactamase-Producing and Acquired AmpC β-Lactamase-Producing Escherichia coli Isolates from Canadian Intensive Care Units
Antimicrobial Agents and Chemotherapy 2008.0